Research We Fund

Filter Current filters include: Dr. Shannon Kolind

Affiliation Province Researcher Area of Research Year Awarded

Hot Topic Research Priority Impact Goals Search

Establishing an imaging biomarker for disease progression in multiple sclerosis

Summary: Therapy efficacy is evaluated using clinical measures in patients with MS, however these measures change slowly and are difficult to measure objectively, therefore clinical trials examining progression in multiple sclerosis (MS) require a very large number of people and long period of time... Read the full article

Canadian Prospective Cohort to Understand Progression in People Living with MS (CanProCo) Pediatric-onset Multiple Sclerosis (POMS) Subcohort

Summary: The onset of MS prior to age 18, during pivotal periods of cognitive maturation and development, has a profound impact on the child and their family. A fundamental unmet need is to understand the impact of pediatric-onset MS (POMS) and the recently identified myelin oligodendrocyte glycoprotein... Read the full article

Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo)

Summary: One of the unmet needs is a better understanding of, and treatment options for, progression in MS. While current therapies in MS aim to slow the progression of the disease, there are no treatment options that successfully alter the trajectory of progression. A key to altering progression in... Read the full article